Literature DB >> 8675705

Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis.

N Goebels1, D Michaelis, M Engelhardt, S Huber, A Bender, D Pongratz, M A Johnson, H Wekerle, J Tschopp, D Jenne, R Hohlfeld.   

Abstract

Polymyositis (PM) and dermatomyositis (DM) are the prototypical inflammatory diseases of skeletal muscle. In PM, CD8+ T cells invade and destroy muscle fibers, whereas humoral effector mechanisms prevail in DM. We studied the expression of the cytotoxic mediator perforin in inflammatory cells in PM and DM muscle by semiquantitative PCR, immunohistochemistry and confocal laser microscopy. Similar levels of perforin mRNA were expressed in PM and DM, and abundant perforin-expressing CD3+CD8+ and CD3+ CD4+ T cells were observed in both diseases. However, there was a striking difference in the intracellular localization of perforin. In DM, perforin was distributed randomly in the cytoplasm of the inflammatory T cells. In contrast, 43% of the CD8+ T cells that contacted a muscle fiber in PM showed perforin located vectorially towards the target muscle fiber. The results suggest (a) that the random distribution of perforin in the cytoplasm of muscle-infiltrating T cells observed in DM reflects nonspecific activation, and (b) that the vectorial orientation observed only in PM reflects the specific recognition via the T cell receptor of an antigen on the muscle fiber surface, pointing to a perforin- and secretion-dependent mechanism of muscle fiber injury.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675705      PMCID: PMC507387          DOI: 10.1172/JCI118749

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

Review 1.  Cell biology of cytotoxic and helper T cell functions: immunofluorescence microscopic studies of single cells and cell couples.

Authors:  A Kupfer; S J Singer
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 2.  Perforin-mediated target cell lysis by cytolytic T lymphocytes.

Authors:  J Tschopp; M Nabholz
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Reorientation and fusion of cytotoxic T lymphocyte granules after interaction with target cells as determined by high resolution cinemicrography.

Authors:  J R Yannelli; J A Sullivan; G L Mandell; V H Engelhard
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

5.  Monoclonal antibody analysis of mononuclear cells in myopathies. III: Immunoelectron microscopy aspects of cell-mediated muscle fiber injury.

Authors:  K Arahata; A G Engel
Journal:  Ann Neurol       Date:  1986-02       Impact factor: 10.422

6.  Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.

Authors:  K Arahata; A G Engel
Journal:  Ann Neurol       Date:  1984-08       Impact factor: 10.422

7.  Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls.

Authors:  I Lundberg; J M Brengman; A G Engel
Journal:  J Neuroimmunol       Date:  1995-12       Impact factor: 3.478

8.  On the mechanism of unidirectional killing in mixtures of two cytotoxic T lymphocytes. Unidirectional polarization of cytoplasmic organelles and the membrane-associated cytoskeleton in the effector cell.

Authors:  A Kupfer; S J Singer; G Dennert
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

9.  Perforin and serine esterase gene expression in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A.

Authors:  C C Liu; S Rafii; A Granelli-Piperno; J A Trapani; J D Young
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

10.  Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells.

Authors:  M J Smyth; J R Ortaldo; Y Shinkai; H Yagita; M Nakata; K Okumura; H A Young
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

View more
  49 in total

1.  Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies.

Authors:  K Nagaraju; N Raben; L Loeffler; T Parker; P J Rochon; E Lee; C Danning; R Wada; C Thompson; G Bahtiyar; J Craft; R Hooft Van Huijsduijnen; P Plotz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

2.  Target specificity of an autoreactive pathogenic human γδ-T cell receptor in myositis.

Authors:  Jessica Bruder; Katherina Siewert; Birgit Obermeier; Joachim Malotka; Peter Scheinert; Josef Kellermann; Takuya Ueda; Reinhard Hohlfeld; Klaus Dornmair
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

3.  The perforin mediated apoptotic pathway in lung injury and fibrosis.

Authors:  H Miyazaki; K Kuwano; K Yoshida; T Maeyama; M Yoshimi; M Fujita; N Hagimoto; R Yoshida; Y Nakanishi
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

Review 4.  Advances in the immunobiology and treatment of inflammatory myopathies.

Authors:  Marinos C Dalakas
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

Review 5.  Autoantigens in systemic autoimmunity: critical partner in pathogenesis.

Authors:  A Rosen; L Casciola-Rosen
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

Review 6.  Type I interferons: crucial participants in disease amplification in autoimmunity.

Authors:  John C Hall; Antony Rosen
Journal:  Nat Rev Rheumatol       Date:  2010-01       Impact factor: 20.543

Review 7.  Dermatomyositis.

Authors:  M S Krathen; D Fiorentino; V P Werth
Journal:  Curr Dir Autoimmun       Date:  2008

Review 8.  Immunotherapy of myositis: issues, concerns and future prospects.

Authors:  Marinos C Dalakas
Journal:  Nat Rev Rheumatol       Date:  2010-02-02       Impact factor: 20.543

9.  Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies.

Authors:  Lisa G Rider; Frederick W Miller
Journal:  JAMA       Date:  2011-01-12       Impact factor: 56.272

10.  ["Therapy-resistant polymyositis" - is the diagnosis correct?]

Authors:  G Ceccon; H C Lehmann; E Neuen-Jacob; G Meng; G R Fink; G Wunderlich
Journal:  Z Rheumatol       Date:  2017-09       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.